Ethical Policy

At Bayrakol Publishing Group, we are committed to adhering to international standards and ethical principles in our publishing processes. Our publications are prepared and published in accordance with the guidelines of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE).

Core Principles

• Editorial processes comply with publishing ethics.
• Conflicts of interest are transparently managed.
• Ethical approval and funding disclosures are required.
• Peer-review is impartial and fair.
• Research must meet ethical standards.

Publishing Ethics & Transparency

• Ethical Approval: Required for human/animal studies.
• Conflict of Interest: Full disclosure by all parties.
• Corrections: Published transparently if needed.

Peer-Review Process

• Double-blind review by at least two reviewers.
• Feedback handled professionally.
• Reviewers follow confidentiality and impartiality.

Editorial Process

1. Submission: Technical compliance check.
2. Review: Double-blind peer review.
3. Decision: Based on reviewer reports.
4. Publication: Scheduled and published.

Open Access Policy

Bayrakol adopts an open access model under the Creative Commons Attribution-NonCommercial (CC BY-NC) license. All content is free to access and share for non-commercial purposes.

Plagiarism Policy

We have zero tolerance for plagiarism. All manuscripts are screened using DupliChecker. High similarity or misconduct results in rejection.

Transparency & Best Practices

• Process Clarity: Transparent publication workflow.
• Open Access: Free under CC BY-NC.
• Fees: Clearly disclosed; no hidden charges.
• Archiving: Long-term preservation via Internet Archive.